AMPH

Amphastar Pharmaceuticals, Inc.

Pharmaceuticals · Pharmaceuticals

$286.92 sample

+1.69 (+0.59%) 1D

Market cap

$1.58T

Price as of

2026-10-24

Latest filing

8-K · 2026-10-15

Alerts

8

Price$286.92 +17.91% 3M daily closessample

286.92233.69

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20INSInsider sell: EVP, Operations
Oct 15SECForm 144 filed
Oct 07INSInsider sell: General Counsel
Sep 28SEC8-K filed: material event
Sep 21SEC10-Q filed
Sep 11INSInsider sell: EVP, Operations
Sep 08INSInsider sell: General Counsel
Sep 02INSInsider buy: Chief Executive Officer

Sign up to see the real AMPH record →

Company facts

SEC EDGAR registration

Name: Amphastar Pharmaceuticals, Inc.
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: -27sample, -100 to +100
Reporting currency: USD

Who is positioning in AMPH

sample

Insiders: 18 insider transactions over 90 days, net selling, $81.8M
Congress: No member trades over 90 days
Institutions · 13F: 20 funds hold $12.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$78.9B +16.7% y/y

Q4 2024Q3 2026

Inventory$49.3B +19.1% y/y

Q4 2024Q3 2026

Accounts receivable$35.1B +8.8% y/y

Q4 2024Q3 2026

Total debt$95.1B +11.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $442.4B +2.7% 3M
Sample peer B: $1.41T -8.6% 3M
Sample peer C: $1.44T +14.2% 3M
Sample peer D: $285.3B -4.7% 3M
Sample peer E: $1.13T -2.3% 3M